2. Adverse effects.
| Characteristic | Rossetti 2011 |
| I1 I2 |
Propofol Thiopental |
| Participants who died (n) Epilepsy‐related I1 Propofol I2 Thiopental |
0 0 |
| Participants who died (n) All causes I1 Propofol I2 Thiopental |
3 1 |
| Adverse events (n) I1 Propofol I2 Thiopental |
14 11 |
| Serious adverse events (n) I1 Propofol I2 Thiopental |
1 1 |
| Duration of ICU stay | Not reported |
| Duration of mechanical ventilation (median (range)) I1 Propofol I2 Thiopental |
17 days (5 to 70 days) 4 days (2 to 28 days) |
| Duration of hospitalisation | Not reported |
| Neurological deficits | Not reported |
| Cognitive deficits | Not reported |
| Haematological toxicity | Not reported |
| Liver toxicity | Not reported |
| Hypersensitivity or drug allergy | Not reported |
| Bronchopneumonia | Not reported |
| Other side effects | Not reported |
I1: intervention 1; I2: intervention 2; ICU: intensive care unit; n: number.